SITC Resource Library

Presentation slides and video from the 2024 Advances in Cancer Immunotherapy^™ (ACI) Series: A Focus on Lung Cancers were presented virtually on June 25, 2024.

Program Organizers

• Ticiana Leal, MD – Emory University
  
• Kai He, MD, PhD – The Ohio State University
  
• Narjust Florez, MD – Dana-Farber Cancer Institute

Target Audience

The Advances in Cancer Immunotherapy™ (ACI) programs aim to reach practicing clinical oncologists, nurses, nurse practitioners, advanced practitioners, pharmacists, emergency physicians, and other allied health professionals who wish to learn the basic principles of cancer immunotherapy and the most up-to-date clinical data for these treatments, in a multitude of disease states/therapeutic areas, in order to inform and integrate into their own clinical practice. In-training oncologists and hospital administrators will also find the program beneficial.

Program Learning Objectives

• Summarize recent updates in cancer immunotherapy for lung cancer and toxicity management for key disease states.
• Implement cancer immunotherapy for lung cancer into clinical practice appropriately.
• Describe management approaches for difficult or refractory immune-related adverse events.
• Describe the use of biomarkers to select appropriate cancer immunotherapies for lung cancer patients.

You can view the program agenda here.

Please note on-demand recordings are not available for continuing education credits.